Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Schizophr Res. 2017 Jan 13;185:88–95. doi: 10.1016/j.schres.2017.01.008

Table 2.

Change from baseline for outcomes of social cognitive function

Oxytocin Placebo
Outcome Variablea Time
Point
(wks)
N LS Mean
(SE)
P-Valueb
Diff>0
N LS Mean
(SE)
P-Valueb
Diff>0
P-Valuec
Trt Diff
Eyes Test total 6 27 −0.48
(0.59)
0.422 27 −1.09
(0.59)
0.070 0.472
12 26 −0.82
(0.67)
0.227 27 0.17
(0.66)
0.798 0.302
ER-40 total 6 28 1.39
(0.55)
0.014 29 0.83
(0.54)
0.129 0.475
12 26 0.14
(0.50)
0.782 29 0.93
(0.48)
0.058 0.270
Brüne-A total 6 28 3.28
(1.22)
0.010 28 4.32
(1.19)
0.001 0.552
12 26 4.52
(1.41)
0.002 29 5.97
(1.36)
0.000 0.469
AIHQ blame bias 6 27 0.05
(0.56)
0.926 29 0.34
(0.53)
0.523 0.712
12 25 −0.66
(0.54)
0.228 29 −0.53
(0.51)
0.308 0.860
Trustworthiness task - 6 27 0.22
(1.63)
0.894 28 1.13
(1.58)
0.479 0.694
 untrustworthy subscale 12 25 0.86
(1.59)
0.591 29 0.24
(1.50)
0.875 0.779
Trustworthiness task - 6 27 1.22
(0.93)
0.194 28 −0.55
(0.90)
0.546 0.183
 trustworthy subscale 12 25 −0.73
(1.02)
0.479 29 −0.29
(0.96)
0.761 0.760

Abbreviations: LS, least squares; ER-40, Emotion Recognition-40 task; AIHQ, Ambiguous Intentions Hostility Questionnaire

a

Models adjusted for baseline value and age in addition to treatment group

b

Test for within-group change

c

Test for between-group change